| Literature DB >> 35875776 |
Xiao Cai1, Peipei Li2, Xue Wang1, Jing Hu3, Lian Wen2, Yajing Duan2, Zhenzhen Mu2, Hong Zhi3.
Abstract
Previous evidence has shown that preoperative hemoglobin is related to poor prognosis after primary total knee arthroplasty. Reviewing cohort research was conducted at the third-level academic medical center in Singapore and involved 2,676 patients. Population statistics, complications, preoperative hemoglobin (Hb) levels, length of hospital stay (LOS), and readmission information of thirty days were obtained. Anemia was defined based on the World Health Organization (WHO). LOS extension was with the definition as no less than six days with >1/75 LOS corresponding to the data. According to the study requirements, we finally collected 2273 patients. We plotted the relationship between hemoglobin levels and length of stay. We analyzed 2273 patients, with 140 cases of Hb ≤ 11.0 g/dL, 831 cases of Hb 11.0-12.9 g/dL, and the other 1320 cases of Hb ≥ 13.0 g/dL. The mean age of patients with prolonged LOS (68.4 ± 8.2 years) was higher than that of patients with familiar LOS (65.9 ± 8.0 years). In addition, patients with extended LOS had higher ASA-PS values, a history of cerebrovascular accidents (CVA), diabetes mellitus (DM), and ischemic heart disease (IHD) (P < 0.001), repeated surgery within 30 days, HB, and operative time (min) (P < 0.01). Variables independently related to increased risk of extended LOS included general anesthesia (GA) (adjusted OR (aOR) 1.4, P=0.005, P=0.005), CVA (aOR 3.0, P < 0.001), DM (aOR 1.4, P=0.032), and HB < 11 g/dL. Variables increased LOS included HB ≥ 13 g/dL (aOR 0.4, P < 0.001) and Hb 11.0-12.9 g/dL (aOR 0.5, P=0.001). Hb was 14 g/dL, and LOS decreased by at least 0.24 days for each 1 g increase in preoperative Hb before the inflection point (95%CI 0.12 to 0.36, P=0.0001). Anemia is familiar in patients receiving elective total knee arthroplasty (TKA) in Singapore. Thus, this study describes that the preoperative hemoglobin was associated with length of stay. We found that on the left where HB was 14, length of stay decreased with increased hemoglobin values. We recommend preoperative correction of anemia to determine the diagnosis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35875776 PMCID: PMC9307341 DOI: 10.1155/2022/3627688
Source DB: PubMed Journal: Comput Intell Neurosci
Figure 1Flowchart shows the derivation of study cohort.
Demographics of patients with normal LOS (≤6 days) versus those with prolonged LOS (>6 days) after primary unilateral TKR.
| Variable | LOS ≤ 6 | LOS > 6 |
| |
|---|---|---|---|---|
| Patient demographics | ||||
| Age | 65.9 ± 8.0 | 68.4 ± 8.2 | <0.001 | |
| Race ( | 0.023 | |||
| Chinese | 1585 (84.4%) | 329 (83.5%) | ||
| Malay | 143 (7.6%) | 20 (5.1%) | ||
| Indian | 101 (5.4%) | 29 (7.4%) | ||
| Others | 50(2.8%) | 16 (4.1%) | ||
| Gender | 0.310 | |||
| Female | 1414 (75.3%) | 306 (77.7%) | ||
| Male | 465 (24.7%) | 88 (22.3%) | ||
| BMI | 0.158 | |||
| ≤25 | 543 (29.4%) | 117 (31.0%) | ||
| >25, ≤30 | 794 (42.9%) | 163 (43.1%) | ||
| >30, ≤35 | 393 (21.3%) | 65 (17.2%) | ||
| >35 | 119 (6.4%) | 33 (8.7%) | ||
| Details of operation | ||||
| Operation duration (min) | 79.6 ± 21.6 | 83.7 ± 25.9 | 0.015 | |
| Type of anesthesia | 0.102 | |||
| RA | 1254 (66.7%) | 242 (61.4%) | ||
| GA | 604 (32.1%) | 146 (37.1%) | ||
| GA RA | 19 (1.0%) | 5 (1.3%) | ||
| GA LA | 1 (0.1%) | 0 (0.0%) | ||
| GA other | 1 (0.1%) | 0 (0.0%) | ||
| RA other | 0 (0.0%) | 1 (0.3%) | ||
| Day of week of op | <0.001 | |||
| Thursday | 459 (24.4%) | 54 (13.7%) | ||
| Tuesday | 408 (21.7%) | 102 (25.9%) | ||
| Wednesday | 320 (17.0%) | 74 (18.8%) | ||
| Monday | 302 (16.1%) | 77 (19.5%) | ||
| Friday | 288 (15.3%) | 72 (18.3%) | ||
| Saturday | 102 (5.4%) | 15 (3.8%) | ||
| Patient comorbidities | ||||
| Smoking | 0.897 | |||
| No | 1697 (90.3%) | 355 (90.1%) | ||
| Yes | 182 (9.7%) | 39 (9.9%) | ||
| DM | 0.001 | |||
| No | 1553 (82.7%) | 298 (75.6%) | ||
| Yes | 326 (17.3%) | 96 (24.4%) | ||
| DM on insulin | ||||
| No | 1398 (74.4%) | 300 (76.1%) | 0.648 | |
| Null | 453 (24.1%) | 87 (22.1%) | ||
| Yes | 28 (1.5%) | 7 (1.8%) | ||
| IHD | 0.025 | |||
| No | 1792 (95.4%) | 365 (92.6%) | ||
| Yes | 87 (4.6%) | 29 (7.4%) | ||
| CCF | 0.583 | |||
| No | 1869 (99.5%) | 391 (99.2%) | ||
| Yes | 10 (0.5%) | 3 (0.8%) | ||
| CVA | <0.001 | |||
| No | 1854 (98.7%) | 375 (95.2%) | ||
| Yes | 25 (1.3%) | 19 (4.8%) | ||
| Creatinine >2 mg/dL | 0.352 | |||
| No | 1671 (88.9%) | 344 (87.3%) | ||
| Null | 199 (10.6%) | 46 (11.7%) | ||
| Yes | 9 (0.5%) | 4 (1.0%) | ||
| Repeat op within 30 days | <0.001 | |||
| No | 1870 (99.7%) | 387 (98.2%) | ||
| Yes | 5 (0.3%) | 7 (1.8%) | ||
| HB categorical | <0.001 | |||
| <11 | 87 (4.6%) | 40 (10.2%) | ||
| ≥11, <13 | 681 (36.2%) | 163(41.4%) | ||
| ≥13 | 1111 (59.1%) | 191 (48.5%) | ||
| ASA-PS | 0.013 | |||
| 1 | 136 (7.2%) | 24 (6.1%) | ||
| 2 | 1650 (87.8%) | 336 (85.3%) | ||
| 3 | 93 (4.9%) | 34 (8.6%) | ||
ASA-PS, American Society of Anesthesiologist Physical Status; CCF, congestive cardiac failure; CVA, cerebrovascular accidents; DM, diabetes mellitus; GA, general anesthesia; IHD, ischemic heart disease; LOS, length of stay; RA, regional anesthesia; TKR, total knee replacement. ASA-PS, American Society of Anesthesiologist Physical Status; CCF, congestive cardiac failure; CVA, cerebrovascular accidents; DM, diabetes mellitus; GA, general anesthesia; IHD, ischemic heart disease; LOS, length of stay; RA, regional anesthesia; REF, reference.
Variables that predict increased LOS in hospital after primary unilateral total knee replacement, based on univariate and multivariate analyses.
| Variable | OR (95%CI) |
| OR (95%CI) |
|
|---|---|---|---|---|
| Age | 1.0 (1.0 to 1.1) | <0.001 | 1.0 (1.0 to 1.1) | <0.001 |
| BMI | ||||
| <25 | REF | REF | ||
| ≥25, <30 | 1.0 (0.7 to 1.3) | 0.857 | 1.0 (0.8 to 1.4) | 0.797 |
| ≥30, <35 | 0.8 (0.6 to 1.1) | 0.168 | 0.9 (0.6 to 1.3) | 0.507 |
| ≥35 | 1.3 (0.8 to 2.0) | 0.292 | 1.6 (1.0 to 2.7) | 0.068 |
| Race | ||||
| Chinese | REF | REF | ||
| Malay | 0.7 (0.4 to 1.1) | 0.109 | 0.6 (0.3 to 1.1) | 0.082 |
| Indian | 1.4 (0.9 to 2.1) | 0.139 | 1.4 (0.9 to 2.2) | 0.167 |
| Gender | ||||
| Female | REF | REF | ||
| Male | 0.9 (0.7 to 1.1) | 0.311 | 0.9 (0.7 to 1.3) | 0.684 |
| Type of anesthesia | ||||
| RA | REF | REF | ||
| GA | 1.3 (1.0 to 1.6) | 0.052 | 1.4 (1.1 to 1.8) | 0.005 |
| GA RA | 1.4 (0.5 to 3.7) | 0.541 | 1.5 (0.5 to 4.1) | 0.479 |
| Operation duration (min) | 1.0 (1.0 to 1.0) | <0.001 | 1.0 (1.0 to 1.0) | 0.005 |
| Day of week of op | ||||
| Thursday | REF | REF | ||
| Tuesday | 2.1 (1.5 to 3.0) | <0.001 | 2.4 (1.7 to 3.5) | <0.001 |
| Wednesday | 2.0 (1.3 to 2.9) | <0.001 | 2.0 (1.3 to 3.0) | <0.001 |
| Monday | 2.2 (1.5 to 3.2) | <0.001 | 2.1 (1.4 to 3.2) | <0.001 |
| Friday | 2.1 (1.4 to 3.1) | <0.001 | 1.9 (1.3 to 2.9) | 0.001 |
| Saturday | 1.2 (0.7 to 2.3) | 0.474 | 1.4 (0.7 to 2.7) | 0.286 |
| HB | ||||
| <11 | REF | REF | REF | |
| ≥11, <13 | 0.5 (0.3, to 0.8) | 0.002 | 0.5 (0.3 to 0.8) | 0.001 |
| ≥13 | 0.4 (0.2, 0.6) | <0.001 | 0.4 (0.2, 0.6) | <0.001 |
| Smoking | ||||
| No | REF | REF | ||
| Yes | 1.0 (0.7 to 1.5) | 0.897 | 1.1 (0.7 to 1.7) | 0.725 |
| DM | ||||
| No | REF | REF | ||
| Yes | 1.5 (1.2 to 2.0) | 0.001 | 1.4 (1.0 to 1.8) | 0.032 |
| IHD | ||||
| No | REF | REF | ||
| Yes | 1.6 (1.1 to 2.5) | 0.026 | 1.3 (0.8 to 2.2) | 0.238 |
| CCF | ||||
| No | REF | REF | ||
| Yes | 1.4 (0.4 to 5.2) | 0.585 | 1.4 (0.3 to 5.4) | 0.671 |
| CVA | ||||
| No | REF | REF | ||
| Yes | 3.8 (2.0 to 6.9) | <0.001 | 3.0 (1.6 to 5.9) | <0.001 |
| Creatinine >2 mg/dL | ||||
| No | REF | REF | ||
| Yes | 2.2 (0.7 to 7.1) | 0.202 | 1.9 (0.5 to 6.9) | 0.313 |
| DM on insulin | ||||
| No | REF | REF | ||
| Yes | 1.2 (0.5 to 2.7) | 0.721 | 1.1 (0.5 to 2.8) | 0.782 |
Figure 2Plot shows the relationship between hemoglobin and length of hospital stay.
Figure 3Plot of the relationship between hemoglobin and length of stay after adjustment for the variables.
Threshold effect analysis between hemoglobin and length of stay for exposure: HB.
| Outcome | Length of stay |
|
|---|---|---|
| Inflection point (K) | 14 | |
| < | −0.24 (0.36, 0.12) | <0.0001 |
| > | 0.15 (0.12, 0.41) | 0.2771 |
| Log-likelihood ratio test | 0.020 |
Data in the table: β (95% CI) P value/OR (95% CI) P value.